Plasma membrane IL-4 receptors can be targeted to eliminate B-chronic lymphocytic leukemia B cells.

被引：0
|
作者：
Kay, NE
Bone, ND
Pittner, BT
Jelinek, DF
Leland, P
Frank, DA
Battle, TE
Puri, RK
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] CBER, Bethesda, MD USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2324
引用
收藏
页码：591A / 591A
页数：1
相关论文
共 50 条
  • [21] ANALYSIS OF SIGNAL TRANSDUCTION IN B-CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS
    DREXLER, HG
    BRENNER, MK
    COUSTANSMITH, E
    GIGNAC, SM
    HOFFBRAND, AV
    BLOOD, 1988, 71 (05) : 1461 - 1469
  • [22] IL-13 HAS ONLY A SUBSET OF IL-4-LIKE ACTIVITIES ON B-CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS
    FLUCKIGER, AC
    BRIERE, F
    ZURAWSKI, G
    BRIDON, JM
    BANCHEREAU, J
    IMMUNOLOGY, 1994, 83 (03) : 397 - 403
  • [23] Histamine receptors mRNA expression in B-cell chronic lymphocytic leukemia cells.
    Zak-Nejmark, T
    Wolowiec, D
    Kraus-Filarska, M
    Jonkisz, A
    Kuliczkowski, K
    BLOOD, 2003, 102 (11) : 346B - 346B
  • [24] Association of B-Chronic lymphocytic leukemia and acute myeloid leukemia
    Carulli, G.
    Marini, A.
    Baccelli, E.
    Lambelet, P.
    Lari, T.
    Azzara, A.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2007, 26 (03) : 421 - 424
  • [25] Receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells
    Bairey, O
    Zimra, Y
    Rabizadeh, E
    Shaklai, M
    BLOOD, 2001, 98 (11) : 281B - 281B
  • [26] Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand
    Buske, C
    Gogowski, G
    Schreiber, K
    RaveFrank, M
    Hiddemann, W
    Wormann, B
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (04) : 329 - 337
  • [27] Plasma levels of oxidative stress markers in patients with B-chronic lymphocytic leukemia
    Vesper, B.
    Altman, M. B.
    Elseth, K. M.
    Roeske, J. C.
    Haines, G. K.
    Altman, K. W.
    Bentz, B. G.
    Radosevich, J. A.
    Yaping, T.
    Zhang, Y.
    Dong, J.
    Wang, D.
    Zelen, I.
    Djurdjevic, P.
    Ristic, P.
    Jovanovic, I.
    Jakovljevic, V.
    Baskic, D.
    Popovic, S.
    Arsenijevic, N.
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2007, 17 : S29 - S29
  • [28] hTERT expression and prognosis in B-chronic lymphocytic leukemia
    Tchirkov, A
    Chaleteix, C
    Magnac, C
    Vasconcelos, Y
    Davi, F
    Michel, A
    Kwìatkowski, F
    Tournilhac, O
    Dighiero, G
    Travade, P
    ANNALS OF ONCOLOGY, 2004, 15 (10) : 1476 - 1480
  • [29] THE NATURE OF THE B-LYMPHOCYTE IN B-CHRONIC LYMPHOCYTIC-LEUKEMIA
    CALIGARISCAPPIO, F
    GOTTARDI, D
    ALFARANO, A
    STACCHINI, A
    GREGORETTI, MG
    GHIA, P
    BERTERO, MT
    NOVARINO, A
    BERGUI, L
    BLOOD CELLS, 1993, 19 (03): : 601 - 613
  • [30] RELEASABLE IGG-FC RECEPTORS AS ACTIVATION MARKERS ON B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) CELLS
    SCHRANZ, V
    AMERICAN JOURNAL OF HEMATOLOGY, 1991, 38 (01) : 78 - 78
12345